Gel casting base for evs3200 Rucaparib
Background: Enteroviruses (EVs) could cause infections and outbreaks of delicate to extreme illnesses, equivalent to central nervous system (CNS) and systemic infections. The contribution of EVs to acute CNS/systemic infections requiring hospitalization was assessed by analysing information extracted from virology laboratory database.
Strategies: Actual-life information obtained from two molecular virology laboratories situated in Northern Italy had been retrieved from databases and analysed retrospectively. The queries used to extract the info had been (i) requests for EV-RNA detection in clear cerebrospinal fluid (CSF) specimens collected from hospitalized sufferers with suspected acute CNS (together with aseptic meningitis, encephalitis, and acute flaccid myelitis/paralysis) or systemic infections (sepsis-like sickness or fever (≥ 38°C) of unknown origin), (ii) CSF samples collected from January 1st, 2015, to December 31st, 2017.
Outcomes: 582 requests of EV-RNA detection in CSF samples collected from as many sufferers of any age had been recorded. EV-RNA was detected in 4.5% of the CSF samples; 92.3% of EV-positive instances had been sufferers < 15 years, 58.3% of whom had been < Three months. EVs circulated all-year-round, and the best EV-positive charges had been noticed from Could to August. The danger of EV an infection and the relative sickness ratio worth amongst youngsters < 1 – yr – outdated had been considerably increased than these noticed for older sufferers.
Conclusions: EV surveillance must be carried out for all pediatric sufferers < 15 years and particularly youngsters lower than 1 yr of age with clinically suspected CNS an infection/systemic infections. The implementation of a laboratory-based surveillance established for analysing the virological information supplied by laboratories that routinely carry out EV molecular testing might allow us to find out the affect of EVs that may trigger infections requiring hospitalization.
Metagenomic water high quality monitoring with a conveyable laboratory
-
We describe the technical feasibility of metagenomic water high quality evaluation utilizing solely transportable gear, for instance mini-vacuum pumps and filtration models, mini-centrifuges, mini-PCR machines and the memory-stick sized MinION of Oxford Nanopore Applied sciences, for the library preparation and sequencing of 16S rRNA gene amplicons.
 gel casting base for evs3100 |
|||
| EVS3100-BASE | Consort | ea | EUR 301 |
 gel casting base for evs3200 |
|||
| EVS3200-BASE | Consort | ea | EUR 301 |
 gel casting base for evs3300 |
|||
| EVS3300-BASE | Consort | ea | EUR 301 |
 Vatalanib, Free Base |
|||
| 2026-25 | Biovision | EUR 305 | |
|
Vatalanib, Free Base |
|||
| 2026-5 | Biovision | EUR 126 | |
 Erlotinib, Free Base |
|||
| 2048-100 | Biovision | EUR 158 | |
|
Erlotinib, Free Base |
|||
| 2048-1000 | Biovision | EUR 387 | |
 Linsitinib, Free base |
|||
| 2294-25 | Biovision | EUR 566 | |
|
Linsitinib, Free base |
|||
| 2294-5 | Biovision | EUR 185 | |
 Tipifarnib, Free base |
|||
| 2296-1 | Biovision | EUR 142 | |
|
Tipifarnib, Free base |
|||
| 2296-5 | Biovision | EUR 414 | |
 Sunitinib, Free base |
|||
| 2097-100 | Biovision | EUR 191 | |
|
Sunitinib, Free base |
|||
| 2097-1000 | Biovision | EUR 501 | |
|
Sunitinib, Free base |
|||
| 2097-25 | Biovision | EUR 115 | |
 Lapatinib, Free base |
|||
| 2138-100 | Biovision | EUR 387 | |
|
Lapatinib, Free base |
|||
| 2138-25 | Biovision | EUR 191 | |
 Ruxolitinib, Free base |
|||
| 2139-100 | Biovision | Ask for price | |
|
Ruxolitinib, Free base |
|||
| 2139-25 | Biovision | EUR 533 | |
|
Ruxolitinib, Free base |
|||
| 2139-5 | Biovision | EUR 207 | |
 Imatinib, Free base |
|||
| 2141-100 | Biovision | EUR 147 | |
|
Imatinib, Free base |
|||
| 2141-1000 | Biovision | EUR 419 | |
) Apatinib (Free base) |
|||
| B1613-25 | Biovision | EUR 414 | |
|
Apatinib (Free base) |
|||
| B1613-5 | Biovision | EUR 142 | |
) Carubicin (Free base) |
|||
| B1853-1 | Biovision | EUR 153 | |
|
Carubicin (Free base) |
|||
| B1853-5 | Biovision | EUR 457 | |
) FIPI (free base) |
|||
| B2372-25 | Biovision | EUR 631 | |
|
FIPI (free base) |
|||
| B2372-5 | Biovision | EUR 196 | |
) Terbinafine (Free base) |
|||
| B2423-250 | Biovision | EUR 207 | |
|
Terbinafine (Free base) |
|||
| B2423-50 | Biovision | EUR 120 | |
) MCC950 (Free base) |
|||
| B1031-1 | Biovision | EUR 153 | |
|
MCC950 (Free base) |
|||
| B1031-5 | Biovision | EUR 457 | |
) THZ1 (Free base) |
|||
| 9664-25 | Biovision | EUR 1023 | |
|
THZ1 (Free base) |
|||
| 9664-5 | Biovision | EUR 294 | |
) R406(free base) |
|||
| E1KS1533 | EnoGene | 2mg | EUR 521 |
 AZD4547, Free Base |
|||
| ADC-P-063 | Creative Biolabs | unit | Ask for price |
 AZD8055, Free Base |
|||
| ADC-P-064 | Creative Biolabs | unit | Ask for price |
 Cyclopamine, Free Base |
|||
| ADC-P-079 | Creative Biolabs | unit | Ask for price |
 Ixabepilone, Free Base |
|||
| ADC-P-104 | Creative Biolabs | unit | Ask for price |
) R406 (free base) |
|||
| A5880-100 | ApexBio | 100 mg | EUR 1210 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
|
R406 (free base) |
|||
| A5880-25 | ApexBio | 25 mg | EUR 514 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
|
R406 (free base) |
|||
| A5880-5 | ApexBio | 5 mg | EUR 166 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
|
R406 (free base) |
|||
| A5880-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 264 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
|
R406 (free base) |
|||
| A5880-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
) Rucaparib (free base) |
|||
| A8893-10 | ApexBio | 10 mg | EUR 200 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
|
Rucaparib (free base) |
|||
| A8893-200 | ApexBio | 200 mg | EUR 1036 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
|
Rucaparib (free base) |
|||
| A8893-5 | ApexBio | 5 mg | EUR 137 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
|
Rucaparib (free base) |
|||
| A8893-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
|
Rucaparib (free base) |
|||
| A8893-50 | ApexBio | 50 mg | EUR 456 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
 LY2835219 free base |
|||
| A3575-100 | ApexBio | 100 mg | EUR 572 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
|||
|
LY2835219 free base |
|||
| A3575-25 | ApexBio | 25 mg | EUR 258 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
|||
|
LY2835219 free base |
|||
| A3575-5 | ApexBio | 5 mg | EUR 142 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
|||
 RPR107393 free base |
|||
| HY-100299 | MedChemExpress | 1mg | EUR 481 |
 FR167344 free base |
|||
| HY-100301 | MedChemExpress | 1mg | EUR 2637 |
 FR183998 free base |
|||
| HY-100302 | MedChemExpress | 1mg | EUR 1127 |
 FR194738 free base |
|||
| HY-100303 | MedChemExpress | 1mg | EUR 1990 |
) ITI214 (free base) |
|||
| HY-12501 | MedChemExpress | 100mg | EUR 2943 |
) AS2863619 (free base) |
|||
| HY-126675 | MedChemExpress | 5mg | EUR 1175 |
) AZD3839 (free base) |
|||
| HY-13438 | MedChemExpress | 50mg | EUR 1014 |
 Ripasudil free base |
|||
| HY-15685A | MedChemExpress | 10mg | EUR 408 |
) Vatalanib (free base) |
|||
| HY-10203 | MedChemExpress | 5mg | EUR 119 |
) Masupirdine (free base) |
|||
| HY-109118 | MedChemExpress | 1mg | EUR 223 |
|
R406 (free base) |
|||
| HY-11108 | MedChemExpress | 10mM/1mL | EUR 231 |
) YM158 (free base) |
|||
| HY-U00355 | MedChemExpress | 1mg | EUR 2309 |
) Xylazine (free base) |
|||
| Q-1445.0025 | Bachem | 25.0g | EUR 321 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
|||
) PLX5622 (free base) |
|||
| B2965-25 | Biovision | 25 mg | EUR 753 |
|
PLX5622 (free base) |
|||
| B2965-5 | Biovision | 5 mg | EUR 227 |
 TMB free base |
|||
| TB0954 | Bio Basic | 1g | EUR 70.88 |
|
|||
 Vemurafenib |
|||
| abx184474-100mg | Abbexa | 100 mg | EUR 592 |
|
|||
|
Vemurafenib |
|||
| HY-12057 | MedChemExpress | 10mM/1mL | EUR 126 |
 RGB-286638, free base |
|||
| 2886-25 | Biovision | EUR 756 | |
|
RGB-286638, free base |
|||
| 2886-5 | Biovision | EUR 229 | |
 StemRegenin 1, Free base |
|||
| 2642-1 | Biovision | EUR 131 | |
|
StemRegenin 1, Free base |
|||
| 2642-5 | Biovision | EUR 332 | |
) GSK-J4 (Free base) |
|||
| 2762-1 | Biovision | EUR 120 | |
|
GSK-J4 (Free base) |
|||
| 2762-5 | Biovision | EUR 262 | |
) BMS-345541 (Free base) |
|||
| B1907-1 | Biovision | EUR 142 | |
|
BMS-345541 (Free base) |
|||
| B1907-5 | Biovision | EUR 414 | |
 UNC-926, free base |
|||
| B2158-25 | Biovision | EUR 631 | |
|
UNC-926, free base |
|||
| B2158-5 | Biovision | EUR 196 | |
 SB-334867 free base |
|||
| B3423-100 | ApexBio | 100 mg | EUR 599 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
|
SB-334867 free base |
|||
| B3423-25 | ApexBio | 25 mg | EUR 290 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
|
SB-334867 free base |
|||
| B3423-5 | ApexBio | 5 mg | EUR 128 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
|
SB-334867 free base |
|||
| B3423-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 131 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
) BMS-345541(free base) |
|||
| B4655-10 | ApexBio | 10 mg | EUR 235 |
|
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways. |
|||
|
BMS-345541(free base) |
|||
| B4655-5 | ApexBio | 5 mg | EUR 171 |
|
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways. |
|||
|
BMS-345541(free base) |
|||
| B4655-50 | ApexBio | 50 mg | EUR 595 |
|
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways. |
|||
 GSK J4 free base |
|||
| B5959-10 | ApexBio | 10 mg | EUR 373 |
|
Description: GSK J4 free base |
|||
|
GSK J4 free base |
|||
| B5959-50 | ApexBio | 50 mg | EUR 1198 |
|
Description: GSK J4 free base |
|||
 Staurosporine, >99% Free Base |
|||
| BC090-001 | GenDepot | 1mg | EUR 246 |
- Utilizing this transportable toolbox on website, we efficiently characterised the microbiome of water samples collected from Birtley Sewage Therapy Plant, UK, and its environs. We additionally demonstrated the applicability of the transportable metagenomics toolbox in a low-income nation by surveying water samples from the Akaki River round Addis Ababa, Ethiopia.
- The 16S rRNA gene sequencing workflow, together with DNA extraction, PCR amplification, sequencing library preparation, and sequencing was completed inside one working day. The metagenomic information grew to become obtainable inside 24-72 h, relying on web pace. Metagenomic evaluation clearly distinguished the microbiome of pristine samples from sewage influenced water samples.
- Metagenomic evaluation recognized the potential function of two bacterial genera not conventionally monitored, Arcobacter and Aeromonas, as predominant faecal air pollution indicators/waterborne hazards. Subsequent quantitative PCR evaluation validated the excessive Arcobacter butzleri abundances noticed within the city influenced Akaki River water samples by transportable subsequent era sequencing with the MinION machine.
Ruxolitinib, Free base |
|||
| 2139-25 | Biovision | EUR 533 | |
Ruxolitinib, Free base |
|||
| 2139-5 | Biovision | EUR 207 | |
 gel casting base 10 cm |
|||
| EVS1100-BASE | Consort | ea | EUR 150 |
 gel casting base 20 cm |
|||
| EVS1300-BASE | Consort | ea | EUR 200 |
gel casting base for evs3100 |
|||
| EVS3100-BASE | Consort | ea | EUR 301 |
gel casting base for evs3200 |
|||
| EVS3200-BASE | Consort | ea | EUR 301 |
gel casting base for evs3300 |
|||
| EVS3300-BASE | Consort | ea | EUR 301 |
Vatalanib, Free Base |
|||
| 2026-25 | Biovision | EUR 305 | |
Vatalanib, Free Base |
|||
| 2026-5 | Biovision | EUR 126 | |
Erlotinib, Free Base |
|||
| 2048-100 | Biovision | EUR 158 | |
Erlotinib, Free Base |
|||
| 2048-1000 | Biovision | EUR 387 | |
Linsitinib, Free base |
|||
| 2294-25 | Biovision | EUR 566 | |
Linsitinib, Free base |
|||
| 2294-5 | Biovision | EUR 185 | |
Tipifarnib, Free base |
|||
| 2296-1 | Biovision | EUR 142 | |
Tipifarnib, Free base |
|||
| 2296-5 | Biovision | EUR 414 | |
Sunitinib, Free base |
|||
| 2097-100 | Biovision | EUR 191 | |
Sunitinib, Free base |
|||
| 2097-1000 | Biovision | EUR 501 | |
Sunitinib, Free base |
|||
| 2097-25 | Biovision | EUR 115 | |
Lapatinib, Free base |
|||
| 2138-100 | Biovision | EUR 387 | |
Lapatinib, Free base |
|||
| 2138-25 | Biovision | EUR 191 | |
Imatinib, Free base |
|||
| 2141-100 | Biovision | EUR 147 | |
Imatinib, Free base |
|||
| 2141-1000 | Biovision | EUR 419 | |
Apatinib (Free base) |
|||
| B1613-25 | Biovision | EUR 414 | |
Apatinib (Free base) |
|||
| B1613-5 | Biovision | EUR 142 | |
Carubicin (Free base) |
|||
| B1853-1 | Biovision | EUR 153 | |
Carubicin (Free base) |
|||
| B1853-5 | Biovision | EUR 457 | |
FIPI (free base) |
|||
| B2372-25 | Biovision | EUR 631 | |
FIPI (free base) |
|||
| B2372-5 | Biovision | EUR 196 | |
Terbinafine (Free base) |
|||
| B2423-250 | Biovision | EUR 207 | |
Terbinafine (Free base) |
|||
| B2423-50 | Biovision | EUR 120 | |
MCC950 (Free base) |
|||
| B1031-1 | Biovision | EUR 153 | |
MCC950 (Free base) |
|||
| B1031-5 | Biovision | EUR 457 | |
THZ1 (Free base) |
|||
| 9664-25 | Biovision | EUR 1023 | |
THZ1 (Free base) |
|||
| 9664-5 | Biovision | EUR 294 | |
R406(free base) |
|||
| E1KS1533 | EnoGene | 2mg | EUR 521 |
AZD4547, Free Base |
|||
| ADC-P-063 | Creative Biolabs | unit | Ask for price |
AZD8055, Free Base |
|||
| ADC-P-064 | Creative Biolabs | unit | Ask for price |
Cyclopamine, Free Base |
|||
| ADC-P-079 | Creative Biolabs | unit | Ask for price |
Ixabepilone, Free Base |
|||
| ADC-P-104 | Creative Biolabs | unit | Ask for price |
R406 (free base) |
|||
| A5880-100 | ApexBio | 100 mg | EUR 1210 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
R406 (free base) |
|||
| A5880-25 | ApexBio | 25 mg | EUR 514 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
R406 (free base) |
|||
| A5880-5 | ApexBio | 5 mg | EUR 166 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
R406 (free base) |
|||
| A5880-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 264 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
R406 (free base) |
|||
| A5880-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
|||
Rucaparib (free base) |
|||
| A8893-10 | ApexBio | 10 mg | EUR 200 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
Rucaparib (free base) |
|||
| A8893-200 | ApexBio | 200 mg | EUR 1036 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
Rucaparib (free base) |
|||
| A8893-5 | ApexBio | 5 mg | EUR 137 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
Rucaparib (free base) |
|||
| A8893-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
Rucaparib (free base) |
|||
| A8893-50 | ApexBio | 50 mg | EUR 456 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
|||
LY2835219 free base |
|||
| A3575-100 | ApexBio | 100 mg | EUR 572 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
|||
LY2835219 free base |
|||
| A3575-25 | ApexBio | 25 mg | EUR 258 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
|||
LY2835219 free base |
|||
| A3575-5 | ApexBio | 5 mg | EUR 142 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
|||
RPR107393 free base |
|||
| HY-100299 | MedChemExpress | 1mg | EUR 481 |
FR167344 free base |
|||
| HY-100301 | MedChemExpress | 1mg | EUR 2637 |
FR183998 free base |
|||
| HY-100302 | MedChemExpress | 1mg | EUR 1127 |
FR194738 free base |
|||
| HY-100303 | MedChemExpress | 1mg | EUR 1990 |
ITI214 (free base) |
|||
| HY-12501 | MedChemExpress | 100mg | EUR 2943 |
AS2863619 (free base) |
|||
| HY-126675 | MedChemExpress | 5mg | EUR 1175 |
AZD3839 (free base) |
|||
| HY-13438 | MedChemExpress | 50mg | EUR 1014 |
Ripasudil free base |
|||
| HY-15685A | MedChemExpress | 10mg | EUR 408 |
Vatalanib (free base) |
|||
| HY-10203 | MedChemExpress | 5mg | EUR 119 |
Masupirdine (free base) |
|||
| HY-109118 | MedChemExpress | 1mg | EUR 223 |
R406 (free base) |
|||
| HY-11108 | MedChemExpress | 10mM/1mL | EUR 231 |
YM158 (free base) |
|||
| HY-U00355 | MedChemExpress | 1mg | EUR 2309 |
Xylazine (free base) |
|||
| Q-1445.0025 | Bachem | 25.0g | EUR 321 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
|||
PLX5622 (free base) |
|||
| B2965-25 | Biovision | 25 mg | EUR 753 |
PLX5622 (free base) |
|||
| B2965-5 | Biovision | 5 mg | EUR 227 |
TMB free base |
|||
| TB0954 | Bio Basic | 1g | EUR 70.88 |
|
|||
RGB-286638, free base |
|||
| 2886-25 | Biovision | EUR 756 | |
RGB-286638, free base |
|||
| 2886-5 | Biovision | EUR 229 | |
StemRegenin 1, Free base |
|||
| 2642-1 | Biovision | EUR 131 | |
StemRegenin 1, Free base |
|||
| 2642-5 | Biovision | EUR 332 | |
GSK-J4 (Free base) |
|||
| 2762-1 | Biovision | EUR 120 | |
GSK-J4 (Free base) |
|||
| 2762-5 | Biovision | EUR 262 | |
BMS-345541 (Free base) |
|||
| B1907-1 | Biovision | EUR 142 | |
BMS-345541 (Free base) |
|||
| B1907-5 | Biovision | EUR 414 | |
UNC-926, free base |
|||
| B2158-25 | Biovision | EUR 631 | |
UNC-926, free base |
|||
| B2158-5 | Biovision | EUR 196 | |
SB-334867 free base |
|||
| B3423-100 | ApexBio | 100 mg | EUR 599 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
SB-334867 free base |
|||
| B3423-25 | ApexBio | 25 mg | EUR 290 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
SB-334867 free base |
|||
| B3423-5 | ApexBio | 5 mg | EUR 128 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
SB-334867 free base |
|||
| B3423-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 131 |
|
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
|||
BMS-345541(free base) |
|||
| B4655-10 | ApexBio | 10 mg | EUR 235 |
|
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways. |
|||
BMS-345541(free base) |
|||
| B4655-5 | ApexBio | 5 mg | EUR 171 |
|
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways. |
|||
BMS-345541(free base) |
|||
| B4655-50 | ApexBio | 50 mg | EUR 595 |
|
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways. |
|||
- Total, our area deployable metagenomics toolbox advances the potential of scientists to comprehensively monitor microbiomes anyplace on this planet, together with within the water, meals and drinks industries, the well being providers, agriculture and past.
Key phrases: Fecal supply monitoring; Discipline kits; Metagenomics; MinION nanopore sequencing; Water high quality; Waterborne hazards.